Identifying patients who benefit the most from implantable defibrillators

Pinkowish, Mary Desmond
June 2000
Patient Care;6/30/2000, Vol. 34 Issue 12, p19
Academic Journal
Discusses the results of a study conducted by researchers at the University of Calgary, Alberta on implantable cardioverter-defibrillators (ICD) in the treatment for ventricular tachyarrythmia. High-risk elderly patients as the population who may benefit most from ICD; Evidence suggesting that ICD is more effective than amiodarone in reducing mortality.


Related Articles

  • Surgery for ventricular tachycardia of left ventricular origin: risk factors for success and long-term outcome von Oppell, Ulrich Otto; Milne, Dave; Okreglicki, Andrzej; Scott Millar, Robert Norman // European Journal of Cardio-Thoracic Surgery;Nov2002, Vol. 22 Issue 5, p762 

    Objectives: To review 26 consecutive patients with sustained monomorphic ventricular tachycardia (VT) of left ventricular origin, who underwent direct VT surgery. Methods: Economic factors precluded the use of an implantable cardioverter defibrillator (ICD) in the majority of these patients, and...

  • Surgical treatment of tachyarrhythmias due to postinfarction left ventricular aneurysm with endoaneurysmorrhaphy and cryoablation Wellens, Francis; Geelen, Peter; Demirsoy, Ergun; Van Praet, Frank; De Geest, Raphael; Degrieck, Ivan; Vanermen, Hugo; Brugada, Pedro // European Journal of Cardio-Thoracic Surgery;Nov2002, Vol. 22 Issue 5, p771 

    Objective: In this study, the efficacy of left ventricular (LV) endoaneurysmorrhaphy and cryoablation without intraoperative electrophysiologic mapping was evaluated in patients with postinfarction LV aneurysm and sustained ventricular tachycardia (VT). Methods: A prospective study was performed...

  • A Questionable Indication For ICD Extraction After Successful VT Ablation. Segreti, Luca; Di Cori, Andrea; Zucchelli, Giulio; Soldati, Ezio; Coluccia, Giovanni; Viani, Stefano; Paperini, Luca; Bongiorni, Maria Grazia // JAFIB: Journal of Atrial Fibrillation;Apr/May2015, Vol. 7 Issue 6, p53 

    Sustained ventricular tachyarrhythmias represent a kind of complication shared by a number of clinical presentations of heart disease, sometimes leading to sudden cardiac death. Many efforts have been made in the fight against such a complication, mainly being represented by the implantable...

  • Diagnosis of arrhythmogenic right ventricular cardiomyopathy. Peters, Matthew N.; Katz, Morgan J.; Alkadri, Mohi E. // Baylor University Medical Center Proceedings;Oct2012, Vol. 25 Issue 4, p349 

    Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an infrequently diagnosed condition with a high incidence of sudden cardiac death. While the only option for cure is orthotopic cardiac transplantation, the use of an implantable cardiac defibrillator can be life saving. Accordingly, the...

  • Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death. Spath, M.A.; O'Brien, B.J.; Spath, Marian A; O'Brien, Bernie J // PharmacoEconomics;2002, Vol. 20 Issue 11, p727 

    The implantable cardioverter defibrillator (ICD) is a therapy for patients at risk of sudden cardiac death due to ventricular tachycardia (VT) or ventricular fibrillation (VF). But the apparent high cost of ICD therapy relative to antiarrhythmic drugs such as amiodarone has raised questions...

  • Characteristics and outcomes of diabetic patients with an implantable cardioverter defibrillator in a real world setting: results from the Israeli ICD registry. Steiner, Hillel; Geist, Michael; Goldenberg, Ilan; Suleiman, Mahmoud; Glikson, Michael; Tenenbaum, Alexander; Swissa, Moshe; Fisman, Enrique Z.; Golovchiner, Gregory; Strasberg, Boris; Barsheshet, Alon // Cardiovascular Diabetology;12/1/2016, Vol. 15, p1 

    Aims: There are limited data regarding the effect of diabetes mellitus (DM) on the risks of both appropriate and inappropriate implantable cardioverter defibrillator (ICD) therapy. The present study was designed to compare the outcome of appropriate and inappropriate ICD therapy in patients with...

  • Inappropriate ICD shocks. Graf, Denis; Pruvot, Etienne // Heart;Dec2007, Vol. 93 Issue 12, p1532 

    The article focuses on the inappropriate shocks caused by the implantable cardioverter-defibrillator (ICD) for episodes of ventricular tachycardia. Several experts show that the high frequency discharges of increasing amplitude are seen before shock delivery. Meanwhile, tracing was found...

  • Chest Pain Associated with Moderator Band Pacing. Goli, Anil K.; Kaszala, Karoly; Osman, Mohammed N.; Lucke, John; Carrillo, Roger // Texas Heart Institute Journal;Sep2014, Vol. 41 Issue 5, p551 

    A 65-year-old man was evaluated for chronic chest pain that had been present for 8 years after placement of a dual-chamber implantable cardioverter-defibrillator to treat inducible ventricular tachycardia. Previous coronary angiography had revealed nonobstructive coronary artery disease and a...

  • Prophylactic left thoracic sympathectomy to prevent electrical storms in CPVT patients needing ICD placement Moray, Amol; Kirk, Edwin P.; Grant, Peter; Camphausen, Christoph // Heart, Lung & Circulation;Nov2011, Vol. 20 Issue 11, p731 

    Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT), a life threatening arrhythmia induced by sympathetic stimulation in susceptible individuals is often refractory to antiarrhythmic agents. First line of treatment, beta-blockers can be ineffective in up to 50% with implantable...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics